Skip to main content
Hit enter to search or ESC to close
Close Search
Menu
Company
Team
Psybrary™
Pipeline
Investors
Investor Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Contact
twitter
facebook
linkedin
Investors
Media Coverage
NASDAQ: ENVB
Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Media Coverage
Enveric signs deal with MindBio [Green Market Rerport]
May 14, 2024
Advancing Mental Health Treatments: The Strategic Collaboration Between Enveric Biosciences and MindBio Therapeutics [Microdose]
May 14, 2024
Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health Disorders [Psychedelic Invest]
May 14, 2024
Microdosing For Depression: Psychedelics Biotech Signs $66.5M Non-Binding Deal To Out-License Novel Psilocin Prodrug Candidate [Benzinga]
May 14, 2024
A Pioneering Push in Cancer Treatment: Enveric Biosciences Advances with Cannabinoid Therapies [Microdose]
May 8, 2024
Cannabinoids With Chemotherapy For Breast Cancer: Psychedelics Biotech Inks $61M License Deal For Patented Methods [Benzinga]
May 8, 2024
Rethinking Mental Health: How Emerging Therapies Are Changing the Game [Newsweek]
May 6, 2024
Unlocking New Horizons: Enveric Biosciences’ Strategic Moves in Biotechnology [Microdose]
April 30, 2024
From LSD to healing minds: Where are we standing in psychedelic drug development? [Labiotech]
March 13, 2024
Avidity to raise $400M; Sato pays Arcutis $25M upfront to license topical roflumilast in Japan [Endpoints News]
February 29, 2024
‹
1
2
3
4
5
…
11
›
Close Menu
Company
Team
Psybrary™
Pipeline
Investors
Investor Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Contact
